These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Conventional ovarian stimulation no longer exists: welcome to the age of individualized ovarian stimulation. Nardo LG; Fleming R; Howles CM; Bosch E; Hamamah S; Ubaldi FM; Hugues JN; Balen AH; Nelson SM Reprod Biomed Online; 2011 Aug; 23(2):141-8. PubMed ID: 21665542 [TBL] [Abstract][Full Text] [Related]
8. [New developments in reproductive medicine]. Imthurn B; Kimmig R; Lang U; Fink D Gynakol Geburtshilfliche Rundsch; 2009; 49(2):53-4. PubMed ID: 19346748 [TBL] [Abstract][Full Text] [Related]
9. New tools for optimizing endometrial receptivity in controlled ovarian hyperstimulation: aromatase inhibitors and LH/(mini)hCG. de Ziegler D; Mattenberger C; Schwarz C; Ibecheole V; Fournet N; Bianchi-Demicheli F Ann N Y Acad Sci; 2004 Dec; 1034():262-77. PubMed ID: 15731318 [TBL] [Abstract][Full Text] [Related]
10. Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation. Fauser BC; Diedrich K; Devroey P; Hum Reprod Update; 2008; 14(1):1-14. PubMed ID: 18006561 [TBL] [Abstract][Full Text] [Related]
11. Poor responder protocols for in-vitro fertilization: options and results. Loutradis D; Vomvolaki E; Drakakis P Curr Opin Obstet Gynecol; 2008 Aug; 20(4):374-8. PubMed ID: 18660689 [TBL] [Abstract][Full Text] [Related]
13. Follicular recruitment is reduced in minimal stimulation for controlled ovarian hyperstimulation using purified human menopausal gonadotropin compared with follicle-stimulating hormone. Park JK; Clark R; Session DR Fertil Steril; 2009 Apr; 91(4 Suppl):1434-6. PubMed ID: 18701097 [TBL] [Abstract][Full Text] [Related]
15. [The use of GnRH antagonists in ovarian stimulation for intrauterine inseminations: is there any interest?]. Pasquier M; Maitrot L; Leperlier F; Dehghani C; Snaifer E; Durnerin IC; Hugues JN Gynecol Obstet Fertil; 2008 Jun; 36(6):644-9. PubMed ID: 18539072 [TBL] [Abstract][Full Text] [Related]
16. Chronic ultra-low dose follicle-stimulating hormone regimen for patients with polycystic ovary syndrome: one click, one follicle, one pregnancy. Orvieto R; Homburg R Fertil Steril; 2009 Apr; 91(4 Suppl):1533-5. PubMed ID: 18990384 [TBL] [Abstract][Full Text] [Related]
17. Induction of ovulation by a potent, orally active, low molecular weight agonist (Org 43553) of the luteinizing hormone receptor. van de Lagemaat R; Timmers CM; Kelder J; van Koppen C; Mosselman S; Hanssen RG Hum Reprod; 2009 Mar; 24(3):640-8. PubMed ID: 19088107 [TBL] [Abstract][Full Text] [Related]
18. Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment. Devroey P; Aboulghar M; Garcia-Velasco J; Griesinger G; Humaidan P; Kolibianakis E; Ledger W; Tomás C; Fauser BC Hum Reprod; 2009 Apr; 24(4):764-74. PubMed ID: 19153090 [TBL] [Abstract][Full Text] [Related]
19. [Management of an ovarian stimulation in case of a Kallmann-De Morsier syndrome. The role of LH]. Heraud MH; Grenier N; Cabry R; Lourdel E; Sanguinet P; Brasseur F; Henry I; Copin H; Merviel P Gynecol Obstet Fertil; 2007 Jun; 35(6):548-55. PubMed ID: 17512237 [TBL] [Abstract][Full Text] [Related]
20. Testosterone patch improves ovarian follicular response to gonadotrophins in a patient with Kallmann's syndrome: a case report. Sipe CS; Van Voorhis BJ Hum Reprod; 2007 May; 22(5):1380-3. PubMed ID: 17341590 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]